Who gets Prostate cancer?

Nork izaten du prostatako minbizia?

Prostatako minbizia nagusiki gizonezkoei eragiten dien gaixotasuna da, eta arriskua adinarekin handitzen da.

Gehienetan 65 urtetik gorako gizonezkoei diagnostikatzen zaie.

Prostatako minbizia izateko arriskua handitu dezaketen faktore batzuk honako hauek dira:

1. Adina: Prostatako minbiziaren arriskua adinarekin handitzen da, eta kasu gehienak 65 urtetik gorako gizonengan gertatzen dira.

2. Familiako historia: Familian prostatako minbizia duten gizonak, batez ere aita edo anaia gaixotasuna dutenak, prostatako minbizia izateko arrisku handiagoa dute.

3. Arraza: Afroamerikar gizonek prostatako minbizia izateko arrisku handiagoa dute eta aukera handiagoa dute adin gazteagoan eta gaixotasunaren forma agresiboagoekin diagnostikatzeko.

4. Genetika: Herentziazko mutazio genetiko batzuek, hala nola BRCA1 eta BRCA2 geneenak, prostatako minbizia izateko arriskua handitu dezakete.

5. Elikadura: Haragi gorri eta esne-produktu gantz handiko elikadurak prostatako minbizia izateko arriskua handitu dezake, eta fruta eta barazki ugari dituen elikadurak arriskua murriztu dezake.

6. Obesitatea: Gehiegizko pisua izateak edo obesitateak prostatako minbizia izateko arriskua handitu dezake, baita minbizia agresiboagoa izateko probabilitatea ere.

7. Bizimodu-faktoreak: Bizimodu-faktore batzuek, hala nola erretzeak eta jarduera fisiko faltak, prostata-minbizia izateko arriskua handitu dezakete.

Garrantzitsua da kontuan hartzea, nahiz eta faktore horiek prostatako minbizia garatzeko arriskua handitu dezaketen, arrisku-faktore horiek dituzten gizon guztiek ez dute gaixotasuna garatuko, eta arrisku-faktore ezagunik gabeko gizon batzuek oraindik ere prostatako minbizia diagnostikatu dezakete.

Erregularki aztertu eta edozein kezka osasun-zerbitzuarekin eztabaidatzeak prostatako minbizia goiz detektatzen lagun dezake, tratatu daitekeen unean.

Erreferentziak

PubMed/Medline https://www.nlm.nih.gov/databases/download/pubmed_medline.html

RefinedWeb https://arxiv.org/abs/2306.01116

Shimodaira K, Nakashima J, Nakagami Y, Hirasawa Y, Hashimoto T, Satake N, Gondo T, Namiki K, Ohori M, Ohno Y: Prognostic Value of Platelet Counts in Patients with Metastatic Prostate Cancer Treated with Endocrine Therapy. Urol J. 2020, 17 (1): 42-49.

Advanced prostate cancer gets a new foe. Johns Hopkins Med Lett Health After 50. 2013, 25 (7): 8.

Vera Badillo FE: Metastatic prostate cancer gets into the biomarker era. Can Urol Assoc J. 2022, 16 (10): 333.

Gerard MJ, Frank-Stromborg M: Screening for prostate cancer in asymptomatic men: clinical, legal, and ethical implications. Oncol Nurs Forum. 1998, 25 (9): 1561-9.

McDowell ME, Occhipinti S, Chambers SK: The influence of family history on cognitive heuristics, risk perceptions, and prostate cancer screening behavior. Health Psychol. 2013, 32 (11): 1158-69.

Razzaghi MR, Mazloomfard MM, Malekian S, Razzaghi Z: Association of macrophage inhibitory factor -173 gene polymorphism with biological behavior of prostate cancer. Urol J. 2019, 16 (1): 32-36.

Erantzukizunik ez: medikoak.

Webgune hau hezkuntza eta informazio helburuetarako bakarrik eskaintzen da eta ez du aholkularitza medikoa edo zerbitzu profesionalik eskaintzen.

Ematen den informazioa ez da osasun-arazo edo gaixotasun bat diagnostikatzeko edo tratatzeko erabili behar, eta aholku mediko pertsonala bilatzen dutenek baimendutako mediku batekin kontsultatu behar dute.

Kontuan izan galderen erantzunak sortzen dituen sare neuronalak ez duela zehaztasunik, batez ere, eduki numerikoari dagokionez. Adibidez, gaixotasun jakin bat duten pertsonen kopurua.

Beti bilatu zure medikuaren aholkua edo beste osasun-zerbitzu kualifikatu bat gaixotasun mediko bati buruz. Sekula ez baztertu aholku mediko profesionala edo atzeratu webgune honetan irakurri duzun zerbaitengatik. Larrialdi mediko bat izan dezakezula uste baduzu, deitu 911 edo joan berehala larrialdietako gelara. Webgune honek edo haren erabilerak ez du mediku-paziente harremana sortzen. Ez BioMedLibek, ez bere langileek, ez webgune honetako inork ez du inolako adierazpenik egiten, espresorik edo inpliziturik, hemen emandako informazioari edo haren erabilerari dagokionez.

Arduragabekeria: egile eskubideak

1998ko Digital Millennium Copyright Act-ek, 17 U.S.C. § 512 (DMCA) -k, egile eskubideen jabeek Interneten agertzen den materialak AEBetako egile eskubideen arabera dituzten eskubideak urratzen dituela uste duten errekurtsoak eskaintzen ditu.

Fede onez uste baduzu gure webgunearekin edo zerbitzuekin lotuta eskuragarri dagoen eduki edo material batek zure egile eskubideak urratzen dituela, zuk (edo zure agenteak) jakinarazpen bat bidal diezagukezu eduki edo materiala kentzeko edo sarbidea blokeatzeko eskatuz.

Jakinarazpenak idatziz bidali behar dira posta elektronikoz (ikus "Kontaktua" atala posta elektronikoaren helbideari buruz).

DMCAk eskatzen du egile eskubideak urratzeari buruzko jakinarazpenean honako informazioa jasotzea: (1) urratzeari buruzko lanaren deskribapena; (2) urratzeari buruzko edukiaren deskribapena eta eduki hori aurkitzea ahalbidetzeko behar beste informazio; (3) zure harremanetarako informazioa, zure helbidea, telefono zenbakia eta posta elektronikoaren helbidea barne; (4) zure adierazpena, sinesmen ona duzula, salatutako moduan dagoen edukia ez dela egile eskubideen jabeak, edo bere agenteak, edo edozein legearen eraginez baimenduta.

(5) zure adierazpen bat, zin faltsuaren zigorraren pean sinatua, jakinarazpenean dagoen informazioa zehatza dela eta urratu direla dioten egile eskubideak betearazteko eskumena duzula;

eta (6) egile eskubideen jabearen edo egile eskubideen jabearen izenean jarduteko baimena duen pertsonaren sinadura fisikoa edo elektronikoa.

Goian aipatutako informazio guztia ez emateak zure kexaren tramitazioa atzeratzea ekar dezake.

Harremanetan jartzea

Bidali iezaguzu mezu elektroniko bat edozein galdera edo iradokizunekin.

Who gets prostate cancer?

Prostate cancer is a disease that primarily affects men, with the risk increasing with age.

It is most commonly diagnosed in men over the age of 65.

Some factors that may increase the risk of developing prostate cancer include:

1. Age: The risk of prostate cancer increases with age, with most cases occurring in men over the age of 65.

2. Family history: Men with a family history of prostate cancer, particularly a father or brother with the disease, have a higher risk of developing prostate cancer themselves.

3. Race: African American men have a higher risk of developing prostate cancer and are more likely to be diagnosed at a younger age and with more aggressive forms of the disease.

4. Genetics: Certain inherited genetic mutations, such as those in the BRCA1 and BRCA2 genes, may increase the risk of developing prostate cancer.

5. Diet: A diet high in red meat and high-fat dairy products may increase the risk of prostate cancer, while a diet rich in fruits and vegetables may decrease the risk.

6. Obesity: Being overweight or obese may increase the risk of developing prostate cancer, as well as the likelihood of the cancer being more aggressive.

7. Lifestyle factors: Certain lifestyle factors, such as smoking and lack of physical activity, may increase the risk of developing prostate cancer.

It is important to note that while these factors may increase the risk of developing prostate cancer, not all men with these risk factors will develop the disease, and some men without any known risk factors may still be diagnosed with prostate cancer.

Regular screening and discussing any concerns with a healthcare provider can help to detect prostate cancer early, when it is most treatable.

Disclaimer: medical

This web site is provided for educational and informational purposes only and does not constitute providing medical advice or professional services.

The information provided should not be used for diagnosing or treating a health problem or disease, and those seeking personal medical advice should consult with a licensed physician.

Please note the neural net that generates answers to the questions, is specially inaccurate when it comes to numeric content. For example, the number of people diagnosed with a specific disease.

Always seek the advice of your doctor or other qualified health provider regarding a medical condition. Never disregard professional medical advice or delay in seeking it because of something you have read on this website. If you think you may have a medical emergency, call 911 or go to the nearest emergency room immediately. No physician-patient relationship is created by this web site or its use. Neither BioMedLib nor its employees, nor any contributor to this web site, makes any representations, express or implied, with respect to the information provided herein or to its use.

Disclaimer: copyright

The Digital Millennium Copyright Act of 1998, 17 U.S.C. § 512 (the “DMCA”) provides recourse for copyright owners who believe that material appearing on the Internet infringes their rights under U.S. copyright law. If you believe in good faith that any content or material made available in connection with our website or services infringes your copyright, you (or your agent) may send us a notice requesting that the content or material be removed, or access to it blocked. Notices must be sent in writing by email (see 'Contact' section for email address) . The DMCA requires that your notice of alleged copyright infringement include the following information: (1) description of the copyrighted work that is the subject of claimed infringement; (2) description of the alleged infringing content and information sufficient to permit us to locate the content; (3) contact information for you, including your address, telephone number and email address; (4) a statement by you that you have a good faith belief that the content in the manner complained of is not authorized by the copyright owner, or its agent, or by the operation of any law; (5) a statement by you, signed under penalty of perjury, that the information in the notification is accurate and that you have the authority to enforce the copyrights that are claimed to be infringed; and (6) a physical or electronic signature of the copyright owner or a person authorized to act on the copyright owner’s behalf. Failure to include all of the above information may result in the delay of the processing of your complaint.